Clinical Trial Update: Durability of Antiviral Activity in Chronic HBV Patients Who Showed Complete Response in L-FMAU-301,302 or 303 Trial

View source ↗

Summary

A clinical trial update reports the durability of antiviral activity in chronic hepatitis B patients who achieved complete response in the L-FMAU-301, 302, or 3…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• L-FMAU

Snippet

Sponsor: Bukwang Pharmaceutical | Conditions: Hepatitis B | Status: COMPLETED